DaBomb Protein Biotech Corp. (TPEX:6578)

DaBomb Protein Biotech Revenue

DaBomb Protein Biotech had revenue of 68.97M TWD in the quarter ending September 30, 2025, with 21.09% growth. This brings the company's revenue in the last twelve months to 310.11M, down -13.07% year-over-year. In the year 2024, DaBomb Protein Biotech had annual revenue of 337.82M, down -12.12%.

• Revenue (ttm): 310.11M
• Revenue Growth: -13.07%
• P/S Ratio: 4.44
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 1.38B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	337.82M	-46.59M	-12.12%
Dec 31, 2023	384.41M	-49.22M	-11.35%
Dec 31, 2022	433.63M	-37.00M	-7.86%
Dec 31, 2021	470.63M	-134.59M	-22.24%
Dec 31, 2020	605.22M	-41.38M	-6.40%